TOMI-T1D

Filter by Category

Filter by Program

Filter by Date

November 7, 2023

C-Path’s T1D Consortium New-onset Article Published in The Lancet Diabetes and Endocrinology

ype 1 Diabetes Consortium, along with external collaborators from Cardiff University and the University of Alberta, today announce

July 18, 2023

AMSTERDAM and TUCSON, Ariz., July 18, 2023 — Critical Path Institute (C-Path) announced today the completion of the integration

September 27, 2022

Board names Dr. Daniel Jorgensen as Chief Executive Officer TUCSON, Ariz., Sept. 27, 2022 — Critical Path Institute (C-Path) tod

September 8, 2022

Swingle joined C-Path in 2019 and was named interim president in 2021 TUCSON, Ariz., Sept. 8, 2022 — Critical Path Institute (C-

December 16, 2020

TUCSON, Ariz., and STOCKHOLM, Sweden. December 16, 2020 — The Critical Path Institute (C-Path) and Diamyd Medical

May 13, 2020

TUCSON, Ariz., and OLDWICK, N.J. May 13, 2020 — The Critical Path Institute (C-Path) and Provention Bio, Inc. (Nas